News
Sistaco Reviews: Everything One Needs to Know Before They Buy
5+ hour, 39+ min ago (925+ words) Are you tired of spending money on salon nails that chip fast and damage your real nails? After looking closely at the products, customer opinions, and overall experience, it becomes easy to see why so many people are interested in…...
HER2-Negative Breast Cancer Pipeline Accelerates as 70+ Pharma Companies Advance Novel Breast Cancer Therapies, Finds Delve Insight | Merck Sharp & Dohme LLC, Astra Zeneca, Roche, Genentech
1+ mon, 1+ week ago (547+ words) Key Takeaways from the HER2-Negative Breast Cancer Pipeline Report On April 13, 2026, Merck Sharp & Dohme LLC initiated a Phase 3 study in triple-negative breast cancer (TNBC) and hormone receptor (HR)-low positive/human epidermal growth factor receptor-2 (HER2) negative breast cancer. On April…...
HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | Delve Insight
1+ mon, 3+ week ago (195+ words) Key Takeaways from the HER2-Negative Breast Cancer Pipeline Report Access Delve Insight's in-depth HER2-Negative Breast Cancer Pipeline Analysis for a closer look at promising breakthroughs @ HER2-Negative Breast Cancer Clinical Trials and Studies The HER2-Negative Breast Cancer Pipeline Report provides a…...
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for c GMP Manufacturing
2+ mon, 1+ week ago (451+ words) Barchart Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for c GMP Manufacturing All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy…...